Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,093 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pulmonx Corporation | $324.78 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $222.04 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $150.71 | 3 | $0 (2023) |
| ABBVIE INC. | $138.90 | 10 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $135.56 | 3 | $0 (2022) |
| Amgen Inc. | $76.32 | 1 | $0 (2022) |
| Novo Nordisk Inc | $31.61 | 2 | $0 (2021) |
| Lilly USA, LLC | $12.84 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $546.82 | 9 | Pulmonx Corporation ($324.78) |
| 2023 | $124.99 | 1 | GlaxoSmithKline, LLC. ($124.99) |
| 2022 | $227.01 | 5 | Biohaven Pharmaceutical Holding Company Ltd. ($135.56) |
| 2021 | $193.94 | 14 | AbbVie Inc. ($123.77) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: PULMONOLOGY | ||||||
| 12/11/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: PULMONOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $115.89 | General |
| 10/17/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $182.07 | General |
| Category: PULMONOLOGY | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $106.15 | General |
| 07/24/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: PULMONOLOGY | ||||||
| 07/01/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: PULMONOLOGY | ||||||
| 06/27/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: PULMONOLOGY | ||||||
| 06/26/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: PULMONOLOGY | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: PRIMARY CARE | ||||||
| 09/16/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: PRIMARY CARE | ||||||
| 07/13/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $76.32 | General |
| Category: Inflammation | ||||||
| 03/31/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PRIMARY CARE | ||||||
| 01/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: RESPIRATORY | ||||||
| 04/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 148 | 195 | $73,183 | $14,338 |
| 2022 | 4 | 131 | 141 | $51,678 | $11,346 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 138 | $51,678 | $9,713 | 18.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $8,414 | $1,845 | 21.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $5,720 | $1,570 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 28 | $7,371 | $1,210 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 70 | $25,692 | $5,133 | 20.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $10,380 | $2,911 | 28.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $7,308 | $1,652 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 32 | $8,298 | $1,650 | 19.9% |
About Brett Cornelius, PA-C
Brett Cornelius, PA-C is a Physician Assistant healthcare provider based in Edinboro, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2020. The National Provider Identifier (NPI) number assigned to this provider is 1083221675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brett Cornelius, PA-C has received a total of $1,093 in payments from pharmaceutical and medical device companies, with $546.82 received in 2024. These payments were reported across 29 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,093).
As a Medicare-enrolled provider, Cornelius has provided services to 279 Medicare beneficiaries, totaling 336 services with total Medicare billing of $25,684. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Edinboro, PA
- Active Since 09/28/2020
- Last Updated 05/08/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1083221675
Products in Payments
- CHARTIS CATHETER (Device) $324.78
- VRAYLAR (Drug) $138.90
- NURTEC ODT (Drug) $135.56
- AREXVY (Drug) $124.99
- Otezla (Drug) $76.32
- Ozempic (Drug) $31.61
- TRELEGY ELLIPTA (Drug) $25.72
- TRULICITY (Drug) $12.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.